Results 1 -
10
of
43
for
"Alopecia," "androgenic," 1
- ... been found to cause palmoplantar keratoderma and congenital alopecia 1, a condition characterized by skin problems, an absence ... the features characteristic of palmoplantar keratoderma and congenital alopecia 1.Other mutations in one copy of the GJA1 ...
- ... National Organization for Rare Disorders (NORD) ClinicalTrials.gov ALOPECIA AREATA 1; AA1 ALOPECIA AREATA 2; AA2 PubMed Biran R, Zlotogorski A, ... Petukhova L, Christiano AM. The genetic architecture of alopecia areata. J Investig Dermatol Symp Proc. 2013 Dec;16(1):S16-22. doi: 10.1038/jidsymp.2013.5. ...
- ... National Organization for Rare Disorders (NORD) ClinicalTrials.gov ALOPECIA, ANDROGENETIC, 1; AGA1 ALOPECIA, ANDROGENETIC, 2; AGA2 ALOPECIA, ANDROGENETIC, 3; ...
- ... of the vitamin D receptor in association with alopecia. Sci Rep. 2017 Jul 11;7(1):5102. doi: 10.1038/s41598-017-05081-x. ...
- ... vitamin D receptor mutations in the development of alopecia. Mol Cell Endocrinol. 2011 Dec 5;347(1-2):90-6. doi: 10.1016/j.mce. ...
- ... the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet. 2005 Jul;77(1):140-8. doi: 10.1086/431425. Epub 2005 ...
- ... clefting syndrome Genetic Testing Registry: Frontonasal dysplasia with alopecia and genital anomaly Frontonasal dysplasia National Organization for Rare Disorders (NORD) FRONTONASAL DYSPLASIA 1; FND1 FRONTONASAL DYSPLASIA 2; FND2 FRONTONASAL DYSPLASIA 3; ...
- ... kidney problems (nephritis), vitamin B12 deficiency, hair loss (alopecia), loss of skin color in blotches (vitiligo), high blood pressure (hypertension), or a small (atrophic) or absent spleen (asplenia). APECED occurs in about 1 in 90,000 to 200,000 people in ...
- T-cell immunodeficiency, congenital alopecia, and nail dystrophy is a type of severe combined immunodeficiency (SCID), which is a group of disorders characterized ...
- ... cases, there is an absence of hair growth (alopecia) in certain areas, often affecting the ... NBCIE is estimated to affect 1 in 200,000 to 300,000 individuals in ...